An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans
Bartus, R.T.; Dean, R.L.; Beer, B.
Psychopharmacology Bulletin 19(2): 168-184
1983
ISSN/ISBN: 0048-5764 PMID: 6408681 Document Number: 219244
Document emailed within 1 workday
Related Documents
Skinner, H.G.; Litzelman, K.; Schwartz, G.G. 2010: Recent clinical trials of vitamin D3 supplementation and serum calcium levels in humans: Implications for vitamin D-based chemoprevention Current Opinion in Investigational Drugs 11(6): 678-687Allain, H.; Lieury, A.; Reymann, J.M.; Martinet, J.P.; Trebon, P.; Decombe, R.; Bentue-Ferrer, D.; Gandon, J.M. 1990: Development of memory-improving drugs Annales de Medecine Interne 141(Suppl 1): 19-25
Yao, H.; Gu, L.-J.; Guo, J.-Y. 2014: Study on effect of astragali radix polysaccharides in improving learning and memory functions in aged rats and its mechanism Zhongguo Zhong Yao Za Zhi 39(11): 2071-2075
Fraser, I.S.; Zeun, S.; Parke, S.; Wilke, B.; Junge, W.; Serrani, M. 2013: Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials Reproductive Sciences 20(7): 745-754
Schrier, A.M.; Angarella, R.; Povar, M.L. 1984: Studies of concept formation by stumptailed monkeys concepts humans monkeys and letter a Journal of Experimental Psychology Animal Behavior Processes 10(4): 564-584
Prasad, V.K. 2019: Improving the design of pivotal clinical trials Clinical Advances in Hematology and Oncology: H&o 17(3): 150-152
Panzer, H. 2000: Improving the conduct and reporting of clinical trials JAMA 283(21): 2787-8; author reply 2789-90
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Sullivan, M.P.; Pullen, D.J.; Crist, W.M.; Brecher, M.; Ramirez, I.; Sabio, H.; Borowitz, M.J.; Head, D.R.; Cerezo, L.; Shuster, J.J. 1990: Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials Leukemia 4(1): 6-11
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Chadly, A. 2004: Ethical implications of clinical trials in Tunisia La Tunisie Medicale 82(11): 985-989
Lal, A.; Sharma, M.L. 1992: An assessment of clinical trials with drugs Indian Journal of Physiology and Pharmacology 36(2): 143-145
Reddy, D.S. 1998: Preclinical and clinical behavioral paradigms for testing drugs that affect learning and memory processes Methods and Findings in Experimental and Clinical Pharmacology 20(3): 249-277
Collins, J.M. 1988: Improving the use of anticancer drugs: clinical pharmacokinetic approaches Israel Journal of Medical Sciences 24(9-10): 483-487
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7